This Little-Known “Daily Grind” Biotech May Be A Better Way To Play The Sector
While most of the attention in the biotech sector is focused on potential COVID-19 treatments or vaccines, the author of today’s article argues that there’s “a better way to play the sector, which is via companies whose roles in the daily grind of drug manufacturing and research will remain crucial regardless of the ups and downs of any particular acute…